These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8967745)

  • 1. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis.
    Gurney ME; Cutting FB; Zhai P; Doble A; Taylor CP; Andrus PK; Hall ED
    Ann Neurol; 1996 Feb; 39(2):147-57. PubMed ID: 8967745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase.
    Gurney ME; Cutting FB; Zhai P; Andrus PK; Hall ED
    Pathol Biol (Paris); 1996 Jan; 44(1):51-6. PubMed ID: 8734301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Reinholz MM; Merkle CM; Poduslo JF
    Exp Neurol; 1999 Sep; 159(1):204-16. PubMed ID: 10486188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
    Tu PH; Gurney ME; Julien JP; Lee VM; Trojanowski JQ
    Lab Invest; 1997 Apr; 76(4):441-56. PubMed ID: 9111507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefit of tianeptine and morphine in a transgenic model of familial amyotrophic lateral sclerosis.
    Chritin M; Savasta M; Besson G
    Amyotroph Lateral Scler; 2006 Mar; 7(1):32-7. PubMed ID: 16546757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of three mutations in the Cu,Zn-superoxide dismutase (Cu,Zn-SOD) gene with familial amyotrophic lateral sclerosis: transduction of human Cu,Zn-SOD into PC12 cells by HIV-1 TAT protein basic domain.
    Chou CM; Huang CJ; Shih CM; Chen YP; Liu TP; Chen CT
    Ann N Y Acad Sci; 2005 May; 1042():303-13. PubMed ID: 15965076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches to therapy of amyotrophic lateral sclerosis.
    Miller RG
    West J Med; 1998 Apr; 168(4):262-3. PubMed ID: 9584665
    [No Abstract]   [Full Text] [Related]  

  • 8. [Familial amyotrophic lateral sclerosis and mutations in the Cu/Zn superoxide dismutase gene].
    Nakano R
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1546-8. PubMed ID: 8752459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of prion protein in a transgenic model of amyotrophic lateral sclerosis.
    Dupuis L; Mbebi C; Gonzalez de Aguilar JL; Rene F; Muller A; de Tapia M; Loeffler JP
    Mol Cell Neurosci; 2002 Feb; 19(2):216-24. PubMed ID: 11860274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Kostic V; Gurney ME; Deng HX; Siddique T; Epstein CJ; Przedborski S
    Ann Neurol; 1997 Apr; 41(4):497-504. PubMed ID: 9124807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of nuclear factor-kappaB activation increased glutamate excitotoxicity in a motoneuron-neuroblastoma hybrid cell line expressing mutant (G93A) Cu/Zn-superoxide dismutase.
    Pyo JS; Ko YS; Kim WH; Kim M; Lee KW; Nam SY; Chung HY; Cho SJ; Baik TK; Lee BL
    J Neurosci Res; 2010 Aug; 88(11):2494-503. PubMed ID: 20623531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies.
    Gurney ME
    J Neurol Sci; 1997 Oct; 152 Suppl 1():S67-73. PubMed ID: 9419057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Liu R; Althaus JS; Ellerbrock BR; Becker DA; Gurney ME
    Ann Neurol; 1998 Nov; 44(5):763-70. PubMed ID: 9818932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic animal models of familial amyotrophic lateral sclerosis.
    Gurney ME
    J Neurol; 1997 May; 244 Suppl 2():S15-20. PubMed ID: 9178166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential treatment of amyotrophic lateral sclerosis with gabapentin: a hypothesis.
    Welty DF; Schielke GP; Rothstein JD
    Ann Pharmacother; 1995 Nov; 29(11):1164-7. PubMed ID: 8573965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of CuII(atsm) in the SOD1-G37R mouse model of amyotrophic lateral sclerosis.
    McAllum EJ; Lim NK; Hickey JL; Paterson BM; Donnelly PS; Li QX; Liddell JR; Barnham KJ; White AR; Crouch PJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Dec; 14(7-8):586-90. PubMed ID: 23952668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model.
    Waibel S; Reuter A; Malessa S; Blaugrund E; Ludolph AC
    J Neurol; 2004 Sep; 251(9):1080-4. PubMed ID: 15372249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant CuZn superoxide dismutase in motor neuron disease.
    Gurney ME; Liu R; Althaus JS; Hall ED; Becker DA
    J Inherit Metab Dis; 1998 Aug; 21(5):587-97. PubMed ID: 9728338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis.
    Gurney ME; Fleck TJ; Himes CS; Hall ED
    Neurology; 1998 Jan; 50(1):62-6. PubMed ID: 9443458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history and the effects of gabapentin in amyotrophic lateral sclerosis.
    Mazzini L; Mora G; Balzarini C; Brigatti M; Pirali I; Comazzi F; Pastore E
    J Neurol Sci; 1998 Oct; 160 Suppl 1():S57-63. PubMed ID: 9851651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.